The burden of disease imposed on helminth-infected
girls and women in childbearing age, especially when pregnant, may
very well define the single most important contribution of
intestinal parasitic infections to the calculation of their global
disease burden. Pregnancy requires extra nutrients, especially
iron, and produces a “physiological anemia” due to hemodilution
[
13,
14]. The anemia results in both decreased appetite and lowered aerobic and physical work capacity, even without the added
weight gain to transport—and this is in girls and women who, in
the tropics, must often carry their youngest child and the
household water supply long distances and also manage to till
their fields daily without mechanized equipment. The total amount
of work a woman can do in a day definitely decreases when she is
anemic, whatever the cause is, and pregnancy plus helminth
infections produce a double burden for women in some rural farming
communities. [
7] Women may even acquire helminth infections
in the process of growing the family's food and thus increase
their degree of anemia in pregnancy, as for example, in Vietnam,
where insufficiently composted human feces may be used as
fertilizer on vegetable crops [
15].
In this study, where more than a thousand young asymptomatic pregnant
women were evaluated, we observed a high prevalence of intestinal
parasitosis (more than 70%), higher than those previously reported for pregnant women in Congo (9%) [
6], Nigeria
(12.5%) [
5], Mexico (38.2%) [
16], Brazil (Sao Paulo State, 45.1%; Rio de Janeiro State, 69.2%)
[
17,
18], and Indonesia (69.7%) [
4]. Although current
evaluated women were transversally analyzed and more than 65%
had anemia, those with anemia corresponded mainly to infected
women (more than 80% of those with anemia). Almost the half of
infected women presented mixed infections, due to two different
parasite species which represented a significant risk to have
anemia, almost twice than those women who did not. But the most
important risk factor to be found with anemia in pregnancy at this
series was to be simply presented an intestinal parasitic
infection at pregnancy (RR = 2.56), independently if this was due
helminths or protozoans. Species adjusted analysis showed that for
this study the most important parasite representing a risk to be
found with anemia at pregnancy was
A lumbricoides (RR = 2.01); the risk of anemia has been frequently reported for
N americanus,
Ancylostoma duodenale, T
trichiura,
Strongyloides stercoralis and
Enterobius vermicularis [
7,
19,
20], but rarely for
A lumbricoides [
21], which may cause intestinal obstruction, liver abscess, local irritation, and damage with
malabsorption as main cellular related events associated with the
infection [
21,
22];
A lumbricoides plays an important role in precipitating protein-energy malnutrition in
undernourished children [
23], this infectious disease is a
form of malnutrition [
21]. Those women infected presented not
just a higher frequency of anemia but also significant lower
levels of hemoglobin and hematocrit and, obviously, higher levels
of eosinophilia. This last, at least in this series, evidenced to
be a diagnostic marker for intestinal parasitosis, and with it,
this type of infection in pregnant women at endemic zones could be
suspected, even if a stool screening is negative (which should be
repeated at least 3 consecutive times). Intestinal parasites
(especially helminths) can be tissue dwelling or intestinal but
all induce a dramatic expansion of the Th2 lymphocyte subset
[
24,
25].
It remains unclear whether these Th2-derived
responses, including IgE, eosinophilia, and mastocytosis are
important in the protective immune response to the parasite, or
are responsible for immune-mediated pathology, or both [
24],
but at least is a paraclinical marker of infection.
Given these results, the importance and potential
impacts of intestinal parasitosis at pregnancy, such as the
anemia, are quietly obvious. Independently to etiology,
parasitoses are associated with conditions for development of
anemia at pregnancy [
7]. This indicates the need for
periodical stool examinations during pregnancy as part of routine
laboratory test in the prenatal control of women. Considering
this, systematic screening and treatment of anemia and associated
factors such as intestinal helminthiasis and protozoasis is needed
for the pregnant women population, as has been established in
other countries [
6], to significantly improve the health of
mothers and children, because it is undoubtedly much better to
enter a pregnancy free of infection and nutritionally replete than
the various alternatives. Existing intervention strategies for
micronutrient support and for the control of common
parasitic infections before or during pregnancy,
particularly intestinal parasitosis, should be followed.
However, further research to identify barriers and priority
approaches to achieving this goal remain very important in
resource-poor settings, where targeted public health efforts are
required [
3].
As has been stated in other studies, it is necessary to modify
some preventive measures of information and education and to give
specific treatment before the pregnancy in order to increase some
of the pregnant women's health indicators. The newborn of mothers
with intestinal parasitosis have a greater probability of being
born with less weight than what is expected [
16], although we
did not evaluate this issue on the current study.
These results enhanced the need for wide implementation of
intermittent iron and folic acid supplementation as a valid
strategy when used as a preventive intervention in prenatal care
settings [
14]. But that antihelminthic therapy could be given
to infected women before conception as public health strategy to
improve iron status may be also considered. Additionally once
diagnosed, if the woman is on the second or third gestation
trimester, it could be treated. In the current study, all women in
this condition were treated with mebendazol 500

mg after first
trimester, as has been recommend by some authors who consider a
possible national strategy for prevention and control is to give a
single dose of this drug during the second or third gestation
trimesters [
26].
The current study reflects the need of routine coproparasitological
study among pregnant women in rural and endemic zones for
intestinal parasites. Even more, further therapeutic and
prophylactic protocols are needed. Additional research on pregnant
intestinal parasitic infection impact on newborn health is
on-going.